Early Stage

Seamlessly Manage the Medication Journey

Seamlessly Manage the Medication Journey


Funding data not publicly available


Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegD 506(c)

Year Founded



Consumer Products, Goods & Services

Tech Sector



Boston, Massachusetts

Medisafe is raising funds on OurCrowd through Reg D 506(c) raise. The company has created a medication management platform that helps people manage their medications. The platform also provides meaningful insights to healthcare companies into people’s daily behaviour. The Medisafe platform supports people in drug purchasing, drug management, and drug refills and serves as a digital companion. Omri Shor and Rotem Shor founded Medisafe in 2012. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $2,210,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Medisafe on OurCrowd 2020
Platform: OurCrowd
Security Type: Equity - Common

Follow company

Follow Medisafe on OurCrowd 2020

Buy Medisafe's Deal Report

Warning: according to the close date for this deal, Medisafe may no longer be accepting investments.

Medisafe Deal Report

Get KingsCrowd’s comprehensive report on Medisafe including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Medisafe is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Medisafe deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge